Regarding non-hematological complications, patients treated with high-dose cisplatin had a higher incidence of grade 3 oral mucositis (47.06% vs 14.29%), grade 3 dermatitis (11.76% vs 4.08%) than that of the low-dose cisplatin group (p<0.05).